Abel Hall LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$864K Sell
13,852
-6,915
-33% -$437K 0.16% 91
2026
Q2
$1.2M Sell
20,767
-333
-2% -$19.1K 0.21% 62
2026
Q1
$1.28M Buy
21,100
+735
+4% +$42.8K 0.27% 48
2025
Q4
$1.1M Buy
20,365
+8,429
+71% +$405K 0.26% 53
2025
Q3
$538K Buy
11,936
+2,340
+24% +$109K 0.22% 83
2025
Q2
$444K Sell
9,596
-6,727
-41% -$330K 0.21% 101
2025
Q1
$996K Sell
16,323
-1,420
-8% -$82.8K 0.6% 26
2024
Q4
$1M Buy
17,743
+341
+2% +$19.1K 0.64% 29
2024
Q3
$900K Buy
17,402
+5,143
+42% +$241K 0.59% 28
2024
Q2
$509K Buy
12,259
+2,412
+24% +$108K 0.36% 43
2024
Q1
$534K Buy
9,847
+5,571
+130% +$284K 0.4% 38
2023
Q4
$219K Buy
+4,276
New +$224K 0.19% 101

Other funds holding BMY

Abel Hall LLC's BMY Position: Q3 2026 in Review

Abel Hall LLC reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q3 2026, selling an estimated $437K and leaving 13,852 shares worth $864K. The position accounts for 0.16% of the portfolio, ranked #91.

Abel Hall LLC first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.28M in Q1 2026. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Abel Hall LLC held 13,852 shares of Bristol-Myers Squibb worth $864K as of Q3 2026.
  • Abel Hall LLC sold 6,915 Bristol-Myers Squibb shares in Q3 2026, an estimated $437K.
  • Bristol-Myers Squibb made up 0.16% of Abel Hall LLC's portfolio in Q3 2026, its #91 holding.
  • Abel Hall LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
  • Abel Hall LLC's Bristol-Myers Squibb position peaked at $1.28M in Q1 2026.
  • 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.